Compounds > celecoxib

celecoxib and transforming growth factor beta

celecoxib has been researched along with transforming growth factor beta in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (11.76)29.6817
2010's12 (70.59)24.3611
2020's3 (17.65)2.80

Authors

AuthorsStudies
Bostrom, MP; Daluiski, A; Hotchkiss, R; Martin, G; Nestor, BJ; Ramsey, KE; Shi, Y; Stephan, DA1
Barreto-de-Souza, V; Bou-Habib, DC; Bozza, PT; Castro-Faria-Neto, HC; Pacheco, GJ; Saraiva, EM; Silva, AR1
Bertagnolli, MM; Carothers, AM; Damas, BC; Davids, JS1
Castro-Sánchez, L; Chávez, E; Moreno, MG; Muriel, P; Salazar, EP; Segovia, J; Shibayama, M; Tsutsumi, V; Vergara, P1
Arber, N; Domany, E; Kazanov, D; Kraus, S; Naumov, I; Sagiv, E; Shapira, S; Sheffer, M1
Arolt, V; Cerovecki, A; Dehning, S; Müller, N; Musil, R; Riedel, M; Schwarz, MJ; Spellmann, I1
Hiramatsu, N; Ishii, M; Kamada, Y; Kawada, N; Kiso, S; Matsumoto, H; Miyoshi, E; Mori, K; Moriwaki, K; Shinzaki, S; Takehara, T; Yoshida, Y1
Aliperti, LA; Cheng, G; Fridlender, ZG; Judy, B; Kapoor, V; Madajewski, B; Okusanya, O; Predina, JD; Quatromoni, J; Singhal, S1
Ruan, LH; Zhang, YF; Zhao, XQ1
Hébert, RL; Karsh, J; Nasrallah, R; Robertson, SJ1
Holick, MF; Jensen, M; Qin, W; Sauter, ER; Smith, C1
Bordignon, J; Cecchini, R; da Silva, RV; de Freitas, RC; Goldenberg, S; Lovo-Martins, MI; Malvezi, AD; Martins-Pinge, MC; Neto, EC; Panis, C; Pinge-Filho, P; Tatakihara, VL; Yamada-Ogatta, SF; Zanluqui, NG1
Chen, TH; Chen, WD; Hsieh, IC; Hung, KC; Lin, SL; Peng, MT; Shie, SS; Wang, CC; Wang, CY; Wen, MS; Yang, CH; Yeh, JK1
Chen, A; Cheng, AM; Chuang, MC; He, H; Liao, SL; Liu, YW; Sheha, H; Tighe, S; Yin, HY1
Antonucci, A; Campo, G; Cimaglia, P; Ferrari, R; Fortini, F; Marracino, L; Moscarelli, M; Rizzo, P; Tonet, E; Vieceli Dalla Sega, F1
Ayoobi, F; Basirjafar, P; Gheitasi, M; Jafarzadeh, A; Khorramdelazad, H; Masoumi, J; Safdel, S; Taghipour, Z; Tavakoli, T; Yousefi, S; Zainodini, N; Zandvakili, R1
Dai, W; Gao, J; Huang, Z; Tang, C; Tong, H; Yang, W; Zhang, L; Zhao, C1

Trials

2 trial(s) available for celecoxib and transforming growth factor beta

ArticleYear
Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment.
    Journal of affective disorders, 2011, Volume: 134, Issue:1-3

    Topics: Adult; Aged; Antidepressive Agents; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Depression; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Psychological Tests; Pyrazoles; Reboxetine; Sulfonamides; Transforming Growth Factor beta; Young Adult

2011
Vitamin D favorably alters the cancer promoting prostaglandin cascade.
    Anticancer research, 2013, Volume: 33, Issue:9

    Topics: Adult; Celecoxib; Cholecalciferol; Cyclooxygenase 2; Dinoprostone; Double-Blind Method; Female; Humans; Middle Aged; Neoplasms; Placebos; Prostaglandin Antagonists; Pyrazoles; Reference Values; RNA; Sulfonamides; Transforming Growth Factor beta; Vitamin D

2013

Other Studies

15 other study(ies) available for celecoxib and transforming growth factor beta

ArticleYear
Cyclooxygenase-2 inhibitors in human skeletal fracture healing.
    Orthopedics, 2006, Volume: 29, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bony Callus; Celecoxib; Cell Line; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Female; Fracture Healing; Fractures, Ununited; Humans; Male; Membrane Proteins; Middle Aged; Osteogenesis; Pyrazoles; Recombinant Proteins; Sulfonamides; Transforming Growth Factor beta

2006
Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis.
    The Journal of infectious diseases, 2006, Sep-15, Volume: 194, Issue:6

    Topics: Animals; Antibodies, Viral; Celecoxib; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Gene Products, tat; HIV Infections; HIV-1; Humans; Leishmania; Leishmaniasis; Macrophages; Pyrazoles; Sulfonamides; tat Gene Products, Human Immunodeficiency Virus; Transforming Growth Factor beta

2006
Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis.
    Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:3

    Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Extracellular Matrix; Female; Fibroblasts; Fibrosis; Genes, APC; Immunoblotting; Immunoenzyme Techniques; Intestinal Neoplasms; Intestines; Mice; Mice, Inbred C57BL; Polysaccharide-Lyases; Pyrazoles; Signal Transduction; Stromal Cells; Sulfonamides; Syndecan-1; Transforming Growth Factor beta

2010
Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat.
    Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:7

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Aspartate Aminotransferases; Carbon Tetrachloride; Celecoxib; Chemical and Drug Induced Liver Injury; Collagen; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; gamma-Glutamyltransferase; Glutathione; Glycogen; Liver; Liver Cirrhosis; Male; Malondialdehyde; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Time Factors; Transforming Growth Factor beta

2010
Gene expression following exposure to celecoxib in humans: pathways of inflammation and carcinogenesis are activated in tumors but not normal tissues.
    Digestion, 2011, Volume: 84, Issue:3

    Topics: Adenocarcinoma; Celecoxib; Cell Cycle; Cell Transformation, Neoplastic; Colonic Polyps; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Gene Expression; Humans; Inflammation; Intestinal Mucosa; Microarray Analysis; Pyrazoles; Random Allocation; RNA, Neoplasm; Signal Transduction; Sulfonamides; Transforming Growth Factor beta

2011
N-Acetylglucosaminyltransferase V regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis.
    Glycobiology, 2012, Volume: 22, Issue:6

    Topics: Animals; Celecoxib; Cyclooxygenase 2; Fatty Liver; Hepatic Stellate Cells; Male; Mice; Mice, Transgenic; N-Acetylgalactosaminyltransferases; Pyrazoles; Sulfonamides; Transforming Growth Factor beta

2012
A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation.
    Cancer biology & therapy, 2012, Volume: 13, Issue:9

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Celecoxib; Cell Line, Tumor; Chemotherapy, Adjuvant; Cyclooxygenase 2 Inhibitors; Disease-Free Survival; Female; Humans; Immunity, Innate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Neoplasms; Postoperative Complications; Pyrazoles; Sulfonamides; Surgical Wound Dehiscence; Transforming Growth Factor beta; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays

2012
[Effects of COX-2 inhibitor celecoxib on expressions of VEGF, b-FGF and TGF-β mRNA in acute leukemia cells].
    Zhongguo shi yan xue ye xue za zhi, 2012, Volume: 20, Issue:5

    Topics: Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Fibroblast Growth Factor 2; Humans; Leukemia; Male; Pyrazoles; RNA, Messenger; Signal Transduction; Sulfonamides; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A

2012
Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental.
    Clinical science (London, England : 1979), 2013, Volume: 124, Issue:11

    Topics: Albumins; Animals; Blood Glucose; Blood Pressure; Celecoxib; Creatinine; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glomerular Basement Membrane; Glomerular Mesangium; Ibuprofen; Male; Mice; Mice, Inbred Strains; Podocytes; Prostaglandins; Pyrazoles; Sulfonamides; Transforming Growth Factor beta

2013
Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cell Line; Cell Survival; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Enzyme-Linked Immunosorbent Assay; Immunity, Innate; Immunohistochemistry; Interleukin-1beta; Myoblasts, Cardiac; Nitric Oxide; Pyrazoles; Rats; Sulfonamides; Transforming Growth Factor alpha; Transforming Growth Factor beta; Trypanosoma cruzi

2014
Circadian CLOCK Mediates Activation of Transforming Growth Factor-β Signaling and Renal Fibrosis through Cyclooxygenase 2.
    The American journal of pathology, 2015, Volume: 185, Issue:12

    Topics: Animals; Celecoxib; Circadian Clocks; CLOCK Proteins; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Fibrosis; Gene Expression; Kidney; Mice, Inbred C57BL; Oxidative Stress; RNA, Messenger; Transforming Growth Factor beta; Ureteral Obstruction

2015
Celecoxib and Pioglitazone as Potential Therapeutics for Regulating TGF-β-Induced Hyaluronan in Dysthyroid Myopathy.
    Investigative ophthalmology & visual science, 2016, Apr-01, Volume: 57, Issue:4

    Topics: Adult; Blotting, Western; Case-Control Studies; Celecoxib; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Male; Middle Aged; Myoblasts; Oculomotor Muscles; Pioglitazone; PPAR gamma; Real-Time Polymerase Chain Reaction; Thiazolidinediones; Transforming Growth Factor beta

2016
COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification.
    International journal of molecular sciences, 2020, Nov-24, Volume: 21, Issue:23

    Topics: Aged; Aged, 80 and over; Animals; Aortic Valve; Aortic Valve Stenosis; Apoptosis; Calcinosis; Celecoxib; Cyclooxygenase 2; Female; Gene Expression Regulation; Humans; Inflammation; Male; Mice; Middle Aged; RNA, Messenger; Transforming Growth Factor beta

2020
Vaccination with celecoxib-treated dendritic cells improved cellular immune responses in an animal breast cancer model.
    Advances in medical sciences, 2023, Volume: 68, Issue:1

    Topics: Animals; Celecoxib; Dendritic Cells; Forkhead Transcription Factors; Granzymes; Immunity, Cellular; Interleukin-12; Lipopolysaccharides; Mice; Neoplasms; Transforming Growth Factor beta; Vaccination; Vaccines

2023
Disruption of cholangiocyte-B cell crosstalk by blocking the CXCL12-CXCR4 axis alleviates liver fibrosis.
    Cellular and molecular life sciences : CMLS, 2023, Nov-27, Volume: 80, Issue:12

    Topics: Animals; Celecoxib; Cell Proliferation; Chemokine CXCL12; Cyclooxygenase 2; Epithelial Cells; Humans; Liver Cirrhosis; Mice; Receptors, CXCR4; Signal Transduction; Transforming Growth Factor beta

2023